Related Experiment Video
Updated: May 20, 2026
Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
Primary cutaneous diffuse large B-cell lymphoma, leg type: diagnostic considerations
1Department of Pathology, Dermatopathology, University of Michigan, Ann Arbor, MI 48109-5602, USA. ahristov@med.umich.edu
Insights
Differentiating primary cutaneous diffuse large B-cell lymphoma, leg type, is crucial for effective treatment. This review highlights key features to distinguish it from other B-cell lymphomas.
Area of Science:
- Dermatology
- Hematopathology
- Oncology
Background:
- Primary cutaneous diffuse large B-cell lymphoma, leg type (PCDLBCL-LT), presents diagnostic challenges due to overlapping features with other lymphomas.
- Accurate diagnosis of PCDLBCL-LT is essential for appropriate clinical management and therapeutic decisions.
Purpose of the Study:
- To comprehensively review the clinical, morphologic, and immunophenotypic characteristics of PCDLBCL-LT.
- To differentiate PCDLBCL-LT from other cutaneous and systemic lymphomas, including other PCDLBCL variants, primary cutaneous follicle center lymphoma, and systemic diffuse large B-cell lymphomas.
Main Methods:
- Systematic review of relevant scientific literature.
- Highlighting key differentiating features for differential diagnosis.
Main Results:
- PCDLBCL-LT exhibits distinct characteristics that allow for its differentiation from other lymphoid neoplasms.
- Key distinguishing features across clinical, morphological, and immunophenotypic profiles are identified.
Conclusions:
- Despite overlapping features, PCDLBCL-LT can be reliably distinguished from its differential diagnoses.
- This distinction is critical for guiding patient treatment strategies and improving outcomes.
Context:
Primary cutaneous diffuse large B-cell lymphoma, leg type, may show features that overlap with other lymphomas. However, timely recognition of this entity can have important clinical and therapeutic implications.
Objective:
To review the clinical, morphologic, and immunophenotypic characteristics of primary cutaneous diffuse large B-cell lymphoma, leg type, and juxtapose these features with other diagnostic considerations. In particular, other variants of primary cutaneous diffuse large B-cell lymphoma, as well as primary cutaneous follicle center lymphoma, will be reviewed. Additionally, systemic/extracutaneous lymphomas will be discussed, including diffuse large B-cell lymphoma, not otherwise specified, Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly, and lymphomatoid granulomatosis.
Data Sources:
Relevant literature will be reviewed and key differentiating findings will be highlighted.
Conclusions:
Although primary cutaneous diffuse large B-cell lymphoma, leg type, may show aspects that overlap with other lymphomas, it can be distinguished from other entities in the differential diagnosis.
